drugset / Trial / NCT00202592

S90652 in Paediatric Hypertension

NCT00202592

Phase 2 Completed 50 enrolled Servier
Non-randomizedSingle-groupOpen-label

Summary

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children

Timeline

Start
2003-11
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Perindopril Small molecule 0.025 mg/kg
Subject Perindopril Small molecule 0.135 mg/kg

Indications